DCAL vs NGLFINE: Stock Comparison

Dishman Carbogen Amcis Limited vs NGL Fine-Chem Limited

Live data: 22 July 2026, 3:03 PM IST • Source: NSE and company filings

Dishman Carbogen Amcis Limited is the larger company by market capitalisation. Dishman Carbogen Amcis Limited shows a lower P/E, while NGL Fine-Chem Limited shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Dishman Carbogen Amcis Limited and NGL Fine-Chem Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, DCAL is more favourable on 3 of 13 scored metrics and NGLFINE on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
DCAL is the larger company
₹2,916 Cr vs ₹2,008 Cr
P/E Ratio
DCAL has a lower P/E
30.58x vs 41.23x
P/B Ratio
DCAL has a lower P/B
0.45x vs 6.03x
EPS
NGLFINE has higher earnings per share
₹78.04 vs ₹6.22
Dividend Yield
NGLFINE has a higher dividend yield
0.05% vs 0%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs 18.9%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs -49.5%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
57.1% vs 18.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDCALNGLFINE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricDCALNGLFINE
Live Price₹186.38₹3,260
Day Change-2%0.7%
Volume1.54 L5,573
52-Week High₹321.95₹3,329
52-Week Low₹128.5₹1,175.5
Distance from 52W High-42.11%-2.07%

Valuation

MetricDCALNGLFINE
Market Cap₹2,916 Cr₹2,008 Cr
P/E Ratio30.58x41.23x
P/B Ratio0.45x6.03x
EPS₹6.22₹78.04
Book Value₹426.9₹532.95
Dividend Yield0%0.05%

Growth

MetricDCALNGLFINE
Revenue Growth (TTM YoY)18.9%57.2%
EPS Growth (TTM YoY)-49.5%1,539.8%
Qtr Sales Growth18.8%57.1%
Qtr Profit Growth-59.4%2,398%

Profitability & Leverage

MetricDCALNGLFINE
ROE1.58%15.7%
ROCE3.15%17%
Net Margin2.51%9.59%
Operating Margin19.3%14.5%
Debt to Equity0.46x0.33x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricDCALNGLFINE
Promoter Holding59.32%72.74%
FII Holding7.45% 0.21 pp0.03% 0.03 pp
DII Holding1.63% 0.36 pp0%
Public Holding31.6% 0.15 pp27.24% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Dishman Carbogen Amcis Limited and NGL Fine-Chem Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.